India has become the center of the novel coronavirus pandemic, but a drop in cases has coincided with the national health ministry's promotion of ivermectin and hydroxychloroquine treatments.
The India Ministry of Health and Family Welfare updated its guidelines on April 28 for treating the asymptomatic and those with mild symptoms of COVID-19
Since then, the data show cases have plunged in some areas, reported a leading promoter in the United States of ivermectin as a treatment for COVID-19, Dr. Pierre Kory, the COVID blog reported.
Didn't we hear last year that President Trump took this medication when he tested positive and was back up working within three days?
But there are 219 peer-reviewed studies indicating the effectiveness of hydroxychloroquine as a treatment and prophylaxis against COVID-19. And 54 peer-reviewed studies show the effectiveness of ivermectin as treatment and prophylaxis against COVID-19.
In February, a peer-reviewed study found that invermectin reduces coronavirus infections, hospitalizations and deaths by about 75%.
Ivermectin, in more than 30 trials around the world, causes "repeated, consistent, large magnitude improvements in clinical outcomes’ at all stages of the disease," according to the study, which was published in the U.S. journal Frontiers of Pharmacology.
The evidence is so strong, the researchers believe, the anti-parasitic drug should become a standard therapy everywhere, hastening global recovery.
Covid cases in India drop when government promotes Trump Drugs - WND A Free Press For A Free People Since 1997 - READ MORE HERE